Health ❯ Healthcare

Cancer Research

Clinical Trials Immunotherapy Biomarkers Clinical Studies Tumor Biology Tumor Microenvironment Survival Rates Innovative Therapies Epidemiology Therapeutics

AstraZeneca Halts Phase III Lung Cancer Trial of Volrustomig

An independent committee found the drug was unlikely to improve progression‑free or overall survival in the trial’s PD‑L1 <1% analysis group.

Stories older than 24h

Cancer Treatment Waits in U.S. Have Lengthened Over the Past Decade, Study Finds

Engineered PRAME T Cells Produce One-Year Remission in Teen With Metastatic Kidney Cancer

Cypherpunk Reports $39.4 Million Q2 Profit Driven by Zcash Revaluation

FDA Authorizes Intermountain to Give Investigational KRAS Drug to Pancreatic Cancer Patients

International Consortium Publishes 665 Validated Patient-Derived Cancer Models

AI Fragmentome Blood Test Improves Detection of Liver Cancer

FDA Grants Priority Review to Pfizer’s Talzenna Plus Xtandi for HRR-Altered mCSPC

WashU Team Uses In‑Body Click Chemistry to Assemble Dual‑Target Cancer Drugs

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

EMA Opens Rolling Review as U.S. Hospitals Start Early Access to Daraxonrasib

Study Finds Large Gaps in Cancer Screening for Sexual and Gender Minority Adults

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

Mumbai Deploys 24 Trained Cancer Patient Navigators Across City Wards

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

Andy Cohen Leads Tribute After WWHL Producer Kyra Samson Dies at 28

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

Daraxonrasib Doubles Survival in Phase 3 Trial for Advanced Pancreatic Cancer

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

FDA Approves Belzutifan With Pembrolizumab as Adjuvant Therapy for Clear Cell Kidney Cancer